CinnaGen Co. Established in 1994, CinnaGen started with a team of four scientists and has since become the largest bio-pharmaceutical manufacturer and biotech exporter in the region. The brand's focus is on developing hi-tech products in the field of biotechnology and related areas.

CinnaGen's product range includes enzymes, molecular biology reagents, PCR kits, and proprietary monoclonal antibodies for blood group typing. The brand has also ventured into therapeutic recombinant proteins and monoclonal antibodies. With a strong emphasis on innovation, CinnaGen aims to address challenges in immunological diseases, infertility, hormone disorders, and oncology.

Additionally, the company offers contract research development services. With over 20% of its total turnover dedicated to research and development activities, CinnaGen is well-positioned to continue leading the biotechnology sector in the region. The brand strives to promote sustainable development in human health by identifying and acquiring selected products through strategic partnerships.

At CinnaGen, quality, patient care, high-tech manufacturing, and cost-effectiveness are of utmost importance, ensuring that their medicines meet high standards and are supplied reliably worldwide